World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 67 2649 2439 1266 1155 161 20818

Willem W. Overwijk publications per year

The chart shows the history of publications by Willem W. Overwijk between 1996 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Willem W. Overwijk published across 30 years, from 1996 to 2025, averaging 10.7 papers a year. Output peaked at 158 publications in 2023. 4 of the 320 publications appeared in the last two years.

No. of publications
50 100 150
Bar chart. Horizontal axis: year, 1996 to 2025. Vertical axis: number of publications, 0 to 158. Peak 158 publications in 2023. 1996: 1 publication 1997: 6 publications 1998: 3 publications 1999: 2 publications 2000: 10 publications 2001: 4 publications 2002: 1 publication 2003: 1 publication 2004: 0 publications 2005: 2 publications 2006: 3 publications 2007: 2 publications 2008: 4 publications 2009: 6 publications 2010: 5 publications 2011: 5 publications 2012: 8 publications 2013: 10 publications 2014: 13 publications 2015: 8 publications 2016: 16 publications 2017: 20 publications 2018: 8 publications 2019: 6 publications 2020: 1 publication 2021: 8 publications 2022: 5 publications 2023: 158 publications 2024: 3 publications 2025: 1 publication
1996 2025

320 publications in total across all disciplines

View publications per year as a table
Willem W. Overwijk: publications per year, 1996 to 2025
Year Publications
1996 1
1997 6
1998 3
1999 2
2000 10
2001 4
2002 1
2003 1
2004 0
2005 2
2006 3
2007 2
2008 4
2009 6
2010 5
2011 5
2012 8
2013 10
2014 13
2015 8
2016 16
2017 20
2018 8
2019 6
2020 1
2021 8
2022 5
2023 158
2024 3
2025 1
Total 320
Download as CSV

Willem W. Overwijk publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Willem W. Overwijk sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 152–161 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 161 publications — 20th percentile

20% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189 161
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Willem W. Overwijk D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Willem W. Overwijk sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 66–67 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 67 D-Index — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167 67
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Overview

Willem W. Overwijk is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research is primarily situated within the fields of Medicine and Immunology and Microbiology, with significant contributions across several subfields including Immunology, Oncology, Neurology, Molecular Biology, and Genetics.

Their work focuses on multiple key topics such as CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Immune Cell Function and Interaction, Neuroblastoma Research and Treatments, Immune cells in cancer, and Microtubule and mitosis dynamics.

Willem W. Overwijk has published extensively, with notable recent papers including:

  • Bempegaldesleukin selectively depletes intratumoral Tregs and potentiates T cell-mediated cancer therapy, 2020, Nature Communications
  • Engineering IL-2 to Give New Life to T Cell Immunotherapy, 2020, Annual Review of Medicine
  • Tilsotolimod with Ipilimumab Drives Tumor Responses in Anti-PD-1 Refractory Melanoma, 2021, Cancer Discovery
  • LFA-1 activation enriches tumor-specific T cells in a cold tumor model and synergizes with CTLA-4 blockade, 2022, Journal of Clinical Investigation
  • Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicity, 2020, Cancer Immunology Immunotherapy

The frequent co-authors collaborating with Overwijk include Manisha Singh, Cara Haymaker, Adi Diab, Jason Roszik, and Patrick Hwu.

Publications by Overwijk have appeared regularly in venues such as The Journal of Immunology, Blood Advances, Frontiers in Immunology, Transplantation and Cellular Therapy, and Cancer Research.

Best Publications

  • Loss of PTEN Promotes Resistance to T Cell–Mediated Immunotherapy

    Weiyi Peng;Jie Qing Chen;Chengwen Liu;Shruti Malu

  • Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells

    Willem W. Overwijk;Marc R. Theoret;Steven E. Finkelstein;Deborah R. Surman

  • BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma

    Dennie Tompers Frederick;Adriano Piris;Alexandria P. Cogdill;Zachary A. Cooper

  • Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade.

    Pei Ling Chen;Whijae Roh;Alexandre Reuben;Zachary A. Cooper

  • T Helper 17 Cells Promote Cytotoxic T Cell Activation in Tumor Immunity

    Natalia Martin-Orozco;Pawel Muranski;Yeonseok Chung;Xuexian O. Yang

  • CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4 T helper cells and hindered by naturally occurring T regulatory cells.

    Paul A. Antony;Ciriaco A. Piccirillo;Akgül Akpinarli;Steven E. Finkelstein

  • GP100/PMEL 17 IS A MURINE TUMOR REJECTION ANTIGEN : INDUCTION OF SELF -REACTIVE, TUMORICIDAL T CELLS USING HIGH-AFFINITY, ALTERED PEPTIDE LIGAND

    Willem W. Overwijk;Allan Tsung;Kari R. Irvine;Maria R. Parkhurst

  • B16 as a mouse model for human melanoma.

    Willem W. Overwijk;Nicholas P. Restifo

  • Vaccination with a recombinant vaccinia virus encoding a “self” antigen induces autoimmune vitiligo and tumor cell destruction in mice: Requirement for CD4+ T lymphocytes

    Willem W. Overwijk;David S. Lee;Deborah R. Surman;Kari R. Irvine

  • PD-1 blockade enhances T-cell migration to tumors by elevating IFN-γ inducible chemokines

    Weiyi Peng;Chengwen Liu;Chunyu Xu;Yanyan Lou

  • Persistent antigen at vaccination sites induces tumor-specific CD8 + T cell sequestration, dysfunction and deletion

    Yared Hailemichael;Zhimin Dai;Nina Jaffarzad;Yang Ye

  • Elucidating the Autoimmune and Antitumor Effector Mechanisms of a Treatment Based on Cytotoxic T Lymphocyte Antigen-4 Blockade in Combination with a B16 Melanoma Vaccine Comparison of Prophylaxis and Therapy

    A. Van Elsas;R. P M Sutmuller;A. A. Hurwitz;J. Ziskin

  • Apoptotic death of CD8+ T lymphocytes after immunization: induction of a suppressive population of Mac-1+/Gr-1+ cells.

    Vincenzo Bronte;Michael Wang;Willem W. Overwijk;Deborah R. Surman

  • BRAF inhibition increases tumor infiltration by T cells and enhances the antitumor activity of adoptive immunotherapy in mice.

    Chengwen Liu;Weiyi Peng;Chunyu Xu;Yanyan Lou

  • Mutational burden, immune checkpoint expression, and mismatch repair in glioma: implications for immune checkpoint immunotherapy

    Tiffany R. Hodges;Martina Ott;Joanne Xiu;Zoran Gatalica

  • Plasmacytoid dendritic cells induce NK cell-dependent, tumor antigen-specific T cell cross-priming and tumor regression in mice

    Chengwen Liu;Yanyan Lou;Gregory Lizée;Hong Qin

  • Inhibition of the B7-H3 immune checkpoint limits tumor growth by enhancing cytotoxic lymphocyte function

    Young Hee Lee;Natalia Martin-Orozco;Natalia Martin-Orozco;Peilin Zheng;Jing Li

  • The immune system in cancer metastasis: friend or foe?

    Louise M.E. Janssen;Emma E. Ramsay;Craig D. Logsdon;Willem W. Overwijk

  • Suppression of Type I IFN Signaling in Tumors Mediates Resistance to Anti-PD-1 Treatment That Can Be Overcome by Radiotherapy.

    Xiaohong Wang;Jonathan E. Schoenhals;Ailin Li;David R. Valdecanas

  • Generation of a new therapeutic peptide that depletes myeloid-derived suppressor cells in tumor-bearing mice

    Hong Qin;Beatrisa Lerman;Ippei Sakamaki;Guowei Wei

  • Visualizing fewer than 10 mouse T cells with an enhanced firefly luciferase in immunocompetent mouse models of cancer

    Brian A. Rabinovich;Yang Ye;Tamara Etto;Jie Qing Chen

Frequent Co-Authors

Patrick Hwu
Patrick Hwu The University of Texas MD Anderson Cancer Center
Nicholas P. Restifo
Nicholas P. Restifo National Institutes of Health
Laszlo Radvanyi
Laszlo Radvanyi Ontario Institute for Cancer Research
Adi Diab
Adi Diab The University of Texas MD Anderson Cancer Center
Steven A. Rosenberg
Steven A. Rosenberg National Institutes of Health
Jennifer A. Wargo
Jennifer A. Wargo The University of Texas MD Anderson Cancer Center
Chantale Bernatchez
Chantale Bernatchez The University of Texas MD Anderson Cancer Center
Michael A. Davies
Michael A. Davies The University of Texas MD Anderson Cancer Center
Padmanee Sharma
Padmanee Sharma The University of Texas MD Anderson Cancer Center
Cara Haymaker
Cara Haymaker The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open new career avenues. Nursing fields, in particular, offer several pathways with flexible online options. Accelerated nurse practitioner programs provide a fast-track route for professionals seeking advanced practice roles without lengthy traditional study periods. These programs are tailored to equip students with clinical expertise efficiently.

Transitioning within nursing specialties is also common, such as moving from Family Nurse Practitioner (FNP) to Acute Care Nurse Practitioner roles. Understanding the requirements for acute care np certification is essential for those wanting to serve acute care settings effectively.

For individuals without a nursing background, online absn programs for non nurses offer an accessible entry point into nursing careers. These programs are designed to build foundational skills and knowledge quickly for new students.

Salary transparency also plays a critical role in career planning. Resources like the dnp salary transparency guide help prospective students and professionals evaluate where their education and skills might be best rewarded across different states.

Best Scientists Citing Willem W. Overwijk

Trending Scientists

Recently Published Articles